Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ventas Inc (NY: VTR )

63.10 -0.45 (-0.71%)
Streaming Delayed Price Updated: 12:27 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ventas Inc

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Raymond James Maintains Strong Buy Rating for Ventas: Here's What You Need To Know
Raymond James has decided to maintain its Strong Buy rating of Ventas (NYSE:VTR) and lower its price target from $60.00 to $55.00. Shares of Ventas are trading up 0.91% over the last 24 hours, at... 
Via Benzinga
Analyst Ratings for Ventas
Analysts have provided the following ratings for Ventas (NYSE:VTR) within the last quarter: 
Via Benzinga
HP To $33, Plus Citigroup Predicts $204 For Baidu
Credit Suisse cut the price target for HP Inc. (NYSE: HPQ) from $39 to $33. HP shares fell 6.6% to $29.05 in pre-market trading. 
Via Benzinga
7 Safe Investments for Seniors to Consider in 2022
Keep your nest egg safe with these save investments for seniors to consider in 2022. 
Via InvestorPlace
Ventas Reports 2022 Second Quarter Results
From Ventas, Inc.
Via Business Wire
Expert Ratings for Ventas
Analysts have provided the following ratings for Ventas (NYSE:VTR) within the last quarter: 
Via Benzinga
Expert Ratings for Ventas
Ventas (NYSE:VTR) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Where Ventas Stands With Analysts
Within the last quarter, Ventas (NYSE:VTR) has observed the following analyst ratings: 
Via Benzinga
7 REITs Trading at a Major Discount Right Now
When REITs are trading at a discount, it means that they are a good value for the money and that there is potential for capital appreciation. 
Via InvestorPlace
Ventas Announces Second Quarter 2022 Earnings Release Date and Conference Call
From Ventas, Inc.
Via Business Wire
Ventas’s Outlook Revised by Fitch Ratings to Stable
From Ventas, Inc.
Via Business Wire
Ominous Death Cross Forms On Ventas's Chart
If history is any guide, there may be trouble ahead for shares of Ventas (NYSE:VTR). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2022
Upgrades 
Via Benzinga
Pamela Boneham Joins Ventas Investment Management Platform as Senior Strategic Advisor
From Ventas, Inc.
Via Business Wire
Ventas to Present at Nareit’s REITweek 2022 Investor Conference
From Ventas, Inc.
Via Business Wire
Ventas Declares Second Quarter 2022 Dividend of $0.45 per Common Share
From Ventas, Inc.
Via Business Wire
Ventas Named a Top Corporate Citizen of 2022 by 3BL Media
From Ventas, Inc.
Via Business Wire
Ventas’s Outlook Revised by S&P Global Ratings to Stable
From Ventas, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Telsey Advisory Group reduced Walmart Inc. (NYSE: WMT) price target from $175 to $160. Walmart shares rose 0.1% to $131.48 in pre-market trading. 
Via Benzinga
Ventas to Participate in Investor Meetings at BMO 2022 Real Estate Summit
From Ventas, Inc.
Via Business Wire
Ventas Earns 2022 ENERGY STAR® Partner of the Year, Energy Management Award
From Ventas, Inc.
Via Business Wire
Ventas Reports 2022 First Quarter Results
From Ventas, Inc
Via Business Wire
Ventas and Sunrise Senior Living Revise Management Agreement to Capitalize on Senior Housing Recovery
From Ventas, Inc.
Via Business Wire
Ventas Appoints Bill “BJ” Grant Senior Vice President, Investor Relations
From Ventas, Inc.
Via Business Wire
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million. 
Via Benzinga
Ventas Confirms End of Proxy Contest Following Withdrawal of Nominations by Land & Buildings
From Ventas, Inc.
Via Business Wire
Land & Buildings Issues Statement on Ventas
From Land & Buildings Investment Management, LLC
Via Business Wire
Ventas Announces First Quarter 2022 Earnings Release Date and Conference Call
From Ventas Inc.
Via Business Wire
Proxy Advisory Firm Glass Lewis Recommends Ventas Shareholders Vote “FOR ALL” of Ventas’s Highly Qualified Directors
From Ventas, Inc.
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.